A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China
Clinical trial NCT06101316 · UNKNOWN
Trial details
- NCT number
- NCT06101316
- Sponsor
- Shanghai Zhimeng Biopharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2023-10-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.